HEADER TRANSFERASE 16-MAY-11 2YIT TITLE STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV1162, A TITLE 2 NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CHK2 CATALYTIC DOMAIN, RESIDUES 210-531; COMPND 5 SYNONYM: CDS1, CHECKPOINT KINASE 2; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDZ1927 KEYWDS TRANSFERASE, STRUCTURE-BASED DRUG DESIGN, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.SELF,G.ZHANG,Y.POMMIER, AUTHOR 2 R.H.SHOEMAKER,D.S.WAUGH REVDAT 3 20-DEC-23 2YIT 1 REMARK REVDAT 2 26-OCT-11 2YIT 1 JRNL REVDAT 1 07-SEP-11 2YIT 0 JRNL AUTH G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.R.SELF,G.ZHANG, JRNL AUTH 2 Y.POMMIER,R.H.SHOEMAKER,D.S.WAUGH JRNL TITL X-RAY STRUCTURES OF CHECKPOINT KINASE 2 IN COMPLEX WITH JRNL TITL 2 INHIBITORS THAT TARGET ITS GATEKEEPER-DEPENDENT HYDROPHOBIC JRNL TITL 3 POCKET. JRNL REF FEBS LETT. V. 585 3245 2011 JRNL REFN ISSN 0014-5793 JRNL PMID 21907711 JRNL DOI 10.1016/J.FEBSLET.2011.08.050 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.T.LOUNTOS,J.E.TROPEA,D.ZHANG,A.G.JOBSON,Y.POMMIER, REMARK 1 AUTH 2 R.H.SHOEMAKER,D.S.WAUGH REMARK 1 TITL CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH NSC REMARK 1 TITL 2 109555, A POTENT AND SELECTIVE INHIBITOR. REMARK 1 REF PROTEIN SCI. V. 18 92 2009 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 19177354 REMARK 1 DOI 10.1002/PRO.16 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0104 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 22111 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1200 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1602 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 104 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2288 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 138 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : 0.08000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.04000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.196 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.169 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.124 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.566 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2377 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1644 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3208 ; 1.318 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4016 ; 0.846 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 286 ; 5.169 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;38.651 ;24.700 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 449 ;14.752 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;20.748 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 362 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2567 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 452 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1433 ; 0.694 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 577 ; 0.137 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2320 ; 1.315 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 944 ; 1.961 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 888 ; 3.249 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 211 A 300 REMARK 3 ORIGIN FOR THE GROUP (A): 53.7640 11.7050 -3.7770 REMARK 3 T TENSOR REMARK 3 T11: 0.2755 T22: 0.3796 REMARK 3 T33: 0.4265 T12: 0.0026 REMARK 3 T13: -0.0800 T23: 0.0893 REMARK 3 L TENSOR REMARK 3 L11: 1.7546 L22: 3.0659 REMARK 3 L33: 0.5292 L12: -1.9729 REMARK 3 L13: 0.1858 L23: 0.3779 REMARK 3 S TENSOR REMARK 3 S11: -0.2084 S12: 0.1027 S13: 0.4413 REMARK 3 S21: 0.1576 S22: 0.0805 S23: -0.5100 REMARK 3 S31: -0.0352 S32: 0.0218 S33: 0.1280 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 301 A 374 REMARK 3 ORIGIN FOR THE GROUP (A): 37.9180 8.6890 -9.9220 REMARK 3 T TENSOR REMARK 3 T11: 0.4535 T22: 0.2922 REMARK 3 T33: 0.4087 T12: -0.0366 REMARK 3 T13: 0.0155 T23: -0.0079 REMARK 3 L TENSOR REMARK 3 L11: 3.2312 L22: 2.3228 REMARK 3 L33: 2.1407 L12: -0.3685 REMARK 3 L13: 0.3261 L23: -0.6105 REMARK 3 S TENSOR REMARK 3 S11: 0.0056 S12: -0.1263 S13: 0.6872 REMARK 3 S21: 0.1364 S22: -0.0625 S23: -0.1172 REMARK 3 S31: -0.6181 S32: 0.0385 S33: 0.0568 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 375 A 448 REMARK 3 ORIGIN FOR THE GROUP (A): 25.7150 4.3260 6.2430 REMARK 3 T TENSOR REMARK 3 T11: 0.3734 T22: 0.2709 REMARK 3 T33: 0.3836 T12: -0.0645 REMARK 3 T13: 0.0666 T23: 0.0589 REMARK 3 L TENSOR REMARK 3 L11: 0.0704 L22: 0.0377 REMARK 3 L33: 1.9914 L12: -0.0421 REMARK 3 L13: -0.1738 L23: 0.1372 REMARK 3 S TENSOR REMARK 3 S11: 0.0338 S12: 0.0492 S13: -0.1080 REMARK 3 S21: -0.0751 S22: 0.0125 S23: 0.0721 REMARK 3 S31: -0.3953 S32: 0.0318 S33: -0.0463 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 449 A 510 REMARK 3 ORIGIN FOR THE GROUP (A): 29.8420 1.0920 -14.7190 REMARK 3 T TENSOR REMARK 3 T11: 0.3239 T22: 0.1863 REMARK 3 T33: 0.1557 T12: 0.0238 REMARK 3 T13: -0.0613 T23: -0.0219 REMARK 3 L TENSOR REMARK 3 L11: 2.0247 L22: 2.3567 REMARK 3 L33: 0.4783 L12: 0.1663 REMARK 3 L13: 0.4821 L23: 0.5295 REMARK 3 S TENSOR REMARK 3 S11: -0.1256 S12: 0.0027 S13: 0.2853 REMARK 3 S21: -0.4164 S22: -0.0661 S23: 0.3389 REMARK 3 S31: -0.3123 S32: -0.1355 S33: 0.1917 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YIT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1290038970. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23346 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 35.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.55000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2W0J REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.8, 0.2M MAGNESIUM REMARK 280 NITRATE, 14%W/V PEG3350, 16%V/V ETHYLENE GLYCOL, PH 7.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.31000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.15500 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 31.15500 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 62.31000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -62.31000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 209 REMARK 465 SER A 210 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 ALA A 267 REMARK 465 VAL A 511 REMARK 465 LEU A 512 REMARK 465 ALA A 513 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 465 GLU A 531 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2067 O HOH A 2075 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 223 -147.59 -124.90 REMARK 500 SER A 228 -148.75 -152.31 REMARK 500 CYS A 231 -9.43 71.96 REMARK 500 ALA A 294 -142.55 -124.54 REMARK 500 ARG A 346 -0.76 73.62 REMARK 500 ASP A 368 85.15 62.96 REMARK 500 PRO A 388 32.62 -88.49 REMARK 500 LEU A 467 40.53 -92.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YIT A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2YCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1531 REMARK 900 RELATED ID: 2YIR RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH REMARK 900 INHIBITOR PV1352 REMARK 900 RELATED ID: 2WTC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2YCR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV976 REMARK 900 RELATED ID: 2YCQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1115 REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XBJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2YCS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788 REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XM9 RELATED DB: PDB REMARK 900 STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF REMARK 900 CHK2 REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 2YIQ RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH REMARK 900 INHIBITOR PV1322 REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2XM8 RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF A SMALL MOLECULE INHIBITOR BOUND TO THE REMARK 900 KINASE DOMAIN OF CHK2 DBREF 2YIT A 210 531 UNP O96017 CHK2_HUMAN 210 531 SEQADV 2YIT MET A 209 UNP O96017 EXPRESSION TAG SEQRES 1 A 323 MET SER VAL TYR PRO LYS ALA LEU ARG ASP GLU TYR ILE SEQRES 2 A 323 MET SER LYS THR LEU GLY SER GLY ALA CYS GLY GLU VAL SEQRES 3 A 323 LYS LEU ALA PHE GLU ARG LYS THR CYS LYS LYS VAL ALA SEQRES 4 A 323 ILE LYS ILE ILE SER LYS ARG LYS PHE ALA ILE GLY SER SEQRES 5 A 323 ALA ARG GLU ALA ASP PRO ALA LEU ASN VAL GLU THR GLU SEQRES 6 A 323 ILE GLU ILE LEU LYS LYS LEU ASN HIS PRO CYS ILE ILE SEQRES 7 A 323 LYS ILE LYS ASN PHE PHE ASP ALA GLU ASP TYR TYR ILE SEQRES 8 A 323 VAL LEU GLU LEU MET GLU GLY GLY GLU LEU PHE ASP LYS SEQRES 9 A 323 VAL VAL GLY ASN LYS ARG LEU LYS GLU ALA THR CYS LYS SEQRES 10 A 323 LEU TYR PHE TYR GLN MET LEU LEU ALA VAL GLN TYR LEU SEQRES 11 A 323 HIS GLU ASN GLY ILE ILE HIS ARG ASP LEU LYS PRO GLU SEQRES 12 A 323 ASN VAL LEU LEU SER SER GLN GLU GLU ASP CYS LEU ILE SEQRES 13 A 323 LYS ILE THR ASP PHE GLY HIS SER LYS ILE LEU GLY GLU SEQRES 14 A 323 THR SER LEU MET ARG THR LEU CYS GLY THR PRO THR TYR SEQRES 15 A 323 LEU ALA PRO GLU VAL LEU VAL SER VAL GLY THR ALA GLY SEQRES 16 A 323 TYR ASN ARG ALA VAL ASP CYS TRP SER LEU GLY VAL ILE SEQRES 17 A 323 LEU PHE ILE CYS LEU SER GLY TYR PRO PRO PHE SER GLU SEQRES 18 A 323 HIS ARG THR GLN VAL SER LEU LYS ASP GLN ILE THR SER SEQRES 19 A 323 GLY LYS TYR ASN PHE ILE PRO GLU VAL TRP ALA GLU VAL SEQRES 20 A 323 SER GLU LYS ALA LEU ASP LEU VAL LYS LYS LEU LEU VAL SEQRES 21 A 323 VAL ASP PRO LYS ALA ARG PHE THR THR GLU GLU ALA LEU SEQRES 22 A 323 ARG HIS PRO TRP LEU GLN ASP GLU ASP MET LYS ARG LYS SEQRES 23 A 323 PHE GLN ASP LEU LEU SER GLU GLU ASN GLU SER THR ALA SEQRES 24 A 323 LEU PRO GLN VAL LEU ALA GLN PRO SER THR SER ARG LYS SEQRES 25 A 323 ARG PRO ARG GLU GLY GLU ALA GLU GLY ALA GLU HET YIT A 600 29 HET NO3 A 601 4 HETNAM YIT N-{4-[(1E)-N-CARBAMIMIDOYLBUTANEHYDRAZONOYL]PHENYL}-5- HETNAM 2 YIT METHOXY-1H-INDOLE-2-CARBOXAMIDE HETNAM NO3 NITRATE ION FORMUL 2 YIT C21 H24 N6 O2 FORMUL 3 NO3 N O3 1- FORMUL 4 HOH *138(H2 O) HELIX 1 1 PRO A 213 GLU A 219 1 7 HELIX 2 2 ASN A 269 LEU A 280 1 12 HELIX 3 3 LEU A 309 VAL A 314 1 6 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 LYS A 349 GLU A 351 5 3 HELIX 6 6 THR A 378 LEU A 384 1 7 HELIX 7 7 ALA A 392 VAL A 399 1 8 HELIX 8 8 ARG A 406 GLY A 423 1 18 HELIX 9 9 SER A 435 GLY A 443 1 9 HELIX 10 10 ILE A 448 ALA A 453 1 6 HELIX 11 11 SER A 456 LEU A 467 1 12 HELIX 12 12 THR A 476 ARG A 482 1 7 HELIX 13 13 HIS A 483 GLN A 487 5 5 HELIX 14 14 ASP A 488 ASN A 503 1 16 SHEET 1 AA 5 TYR A 220 GLY A 227 0 SHEET 2 AA 5 GLY A 232 GLU A 239 -1 O VAL A 234 N LEU A 226 SHEET 3 AA 5 LYS A 244 SER A 252 -1 O LYS A 244 N GLU A 239 SHEET 4 AA 5 ASP A 296 GLU A 302 -1 O TYR A 297 N ILE A 251 SHEET 5 AA 5 ASN A 290 ASP A 293 -1 O ASN A 290 N VAL A 300 SHEET 1 AB 3 GLY A 307 GLU A 308 0 SHEET 2 AB 3 VAL A 353 LEU A 355 -1 N LEU A 355 O GLY A 307 SHEET 3 AB 3 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SHEET 1 AC 2 ILE A 343 ILE A 344 0 SHEET 2 AC 2 LYS A 373 ILE A 374 -1 O LYS A 373 N ILE A 344 SITE 1 AC1 14 LEU A 226 VAL A 234 ILE A 251 GLU A 273 SITE 2 AC1 14 LEU A 277 MET A 304 GLU A 305 GLY A 307 SITE 3 AC1 14 LEU A 354 THR A 367 ASP A 368 GLY A 370 SITE 4 AC1 14 HOH A2035 HOH A2042 SITE 1 AC2 5 LEU A 375 GLY A 403 TYR A 404 ASN A 405 SITE 2 AC2 5 ARG A 406 CRYST1 91.208 91.208 93.465 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010964 0.006330 0.000000 0.00000 SCALE2 0.000000 0.012660 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010699 0.00000